NBPF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.85509998660439E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.95356999999063E-05 |
Normal-vs-Stage2 |
1.25429999997539E-06 |
Normal-vs-Stage3 |
3.8968828164343E-14 |
Normal-vs-Stage4 |
3.43225448062867E-12 |
Stage1-vs-Stage2 |
1.461810E-01 |
Stage1-vs-Stage3 |
2.12870000004806E-06 |
Stage1-vs-Stage4 |
2.04990000000072E-05 |
Stage2-vs-Stage3 |
7.366300E-02 |
Stage2-vs-Stage4 |
6.803600E-02 |
Stage3-vs-Stage4 |
8.173800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63279945120109E-10 |
Normal-vs-AfricanAmerican |
3.751100E-04 |
Normal-vs-Asian |
6.024000E-01 |
Caucasian-vs-AfricanAmerican |
7.128800E-01 |
Caucasian-vs-Asian |
8.184100E-02 |
AfricanAmerican-vs-Asian |
2.473000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.24509982721588E-10 |
Normal-vs-Female |
2.84750000023593E-07 |
Male-vs-Female |
3.532800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.58390000000775E-05 |
Normal-vs-Age(41-60Yrs) |
9.95800000236358E-08 |
Normal-vs-Age(61-80Yrs) |
2.32679997491658E-09 |
Normal-vs-Age(81-100Yrs) |
2.43009999999488E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.787400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.305400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.265200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.532200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.430000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.544400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.934000E-01 |
Normal-vs-Grade 2 |
4.01410000000491E-05 |
Normal-vs-Grade 3 |
2.38129516105801E-11 |
Normal-vs-Grade 4 |
1.62458935193399E-12 |
Grade 1-vs-Grade 2 |
4.000400E-01 |
Grade 1-vs-Grade 3 |
2.655900E-02 |
Grade 1-vs-Grade 4 |
7.441100E-03 |
Grade 2-vs-Grade 3 |
7.358800E-04 |
Grade 2-vs-Grade 4 |
7.03910041366385E-10 |
Grade 3-vs-Grade 4 |
4.605300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.52709999999524E-05 |
Normal-vs-ccB subtype |
2.42980002784776E-09 |
ccA subtype-vs-ccB subtype |
3.659000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.59370011316207E-10 |
Normal-vs-N1 |
3.71960000000726E-05 |
N0-vs-N1 |
3.436200E-01 |
|
|